Also, the Bcl-2 protein is one of the most important members associated with acquired resistance (not primarily against sorafenib), due to its capacity to inhibit caspase activation through cytochrome c or the entrance of glutathione into the nucleus of HCC cells [95]. This evidence concerns the gene CYCS and hepatocellular carcinoma.